However, mean GH and postglucose GH nadir levels at last follow-up (phase 3) were significantly lower than phase 1 only in patients of group B (i.e., postglucose GH nadir < 0.4 μ g/L, resp., P = 0.03 and P = 0.002), whereas the decrease did not reach statistical significance in patients of group A ( Figure 1 ).
← all excerpts
Reevaluation of Acromegalic Patients in Long-Term Remission according to Newly Proposed Consensus Criteria for Control of Disease.
1
—
—